A Dynorphin Theory of Depression and Bipolar Disorder
Fuente:
arXiv
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Preprint |
| Publié: |
2024
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| _version_ | 1866916355579576320 |
|---|---|
| author | Rappoport, Ari |
| author_facet | Rappoport, Ari |
| contents | Major depressive disorder (MDD) is a debilitating health condition affecting a substantial part of the world's population. At present, there is no biological theory of MDD, and treatment is partial at best. Here I present a theory of MDD that explains its etiology, symptoms, pathophysiology, and treatment. MDD involves stressful life events that the person does not manage to resolve. In this situation animals normally execute a 'disengage' survival response. In MDD, this response is chronically executed, leading to depressed mood and the somatic MDD symptoms. To explain the biological mechanisms involved, I present a novel theory of opioids, where each opioid mediates one of the basic survival responses. The opioid mediating 'disengage' is dynorphin. The paper presents strong evidence for chronic dynorphin signaling in MDD and for its causal role in the disorder. The theory also explains bipolar disorder, and the mechanisms behind the treatment of both disorders. |
| format | Preprint |
| id |
arxiv_https___arxiv_org_abs_2408_06763 |
| institution | arXiv |
| publishDate | 2024 |
| record_format | arxiv |
| spellingShingle | A Dynorphin Theory of Depression and Bipolar Disorder Rappoport, Ari Neurons and Cognition Major depressive disorder (MDD) is a debilitating health condition affecting a substantial part of the world's population. At present, there is no biological theory of MDD, and treatment is partial at best. Here I present a theory of MDD that explains its etiology, symptoms, pathophysiology, and treatment. MDD involves stressful life events that the person does not manage to resolve. In this situation animals normally execute a 'disengage' survival response. In MDD, this response is chronically executed, leading to depressed mood and the somatic MDD symptoms. To explain the biological mechanisms involved, I present a novel theory of opioids, where each opioid mediates one of the basic survival responses. The opioid mediating 'disengage' is dynorphin. The paper presents strong evidence for chronic dynorphin signaling in MDD and for its causal role in the disorder. The theory also explains bipolar disorder, and the mechanisms behind the treatment of both disorders. |
| title | A Dynorphin Theory of Depression and Bipolar Disorder |
| topic | Neurons and Cognition |
| url | https://arxiv.org/abs/2408.06763 |